How far has life expectancy in the U.S. dropped? Shocking stats tell all
Life expectancy in the US took a sharp hit in 2020 when the average fell by roughly one year, driven by COVID-19 and a rise in drug overdoses. The drop came after decades of steady gains tied to lower infant mortality, better sanitation, vaccines, and fewer deaths from infectious diseases. The National Center for Health Statistics documented the 2020 decline and the subsequent climb back to pre-pandemic levels, showing how quickly a single health crisis could erase long-term progress.
Past life expectancy
From around 47 years in 1900, life expectancy in the US climbed to a peak of nearly 79 years by 2014. That steady rise reflected broad improvements in public health. The 2020 decline reversed some of those gains, yet recent CDC figures show life expectancy in the US reached 79.0 years in 2024, exceeding the 2014 high and completing a full rebound after the 2020-2021 drops.
“Excess deaths”
Excess deaths measure the gap between observed and expected mortality. The concept helped analysts capture deaths tied to COVID-19 even when the virus was not listed on certificates. COVID-attributable excess deaths have since fallen sharply. Deaths from the virus dropped 37 percent from 2023 to 2024, and overall age-adjusted death rates declined across demographic groups, reducing the weight of excess mortality in current life expectancy calculations.
Other factors & demographics
Drug overdoses contributed to pre-pandemic dips in life expectancy in the US. The 2020 data also revealed clear racial and gender gaps: life expectancy for non-Hispanic Black men fell more than three years while white men saw an 0.8-year drop; non-Hispanic Black women lost over two years compared with 0.7 years for white women. Post-2020 figures show larger gains for Black, Hispanic, and American Indian or Alaska Native populations between 2021 and 2023. Overdose deaths have also declined substantially, returning closer to pre-pandemic totals by 2025.
Different data
Earlier United Nations projections excluded COVID impacts and showed a modest 2020 increase. Current UN World Population Prospects 2024 incorporates observed recovery trends since 2022. US-specific data through 2024 now confirms the rebound, aligning observed national figures with updated global models that account for the post-pandemic period.
Recovery Trajectory Since 2021
Life expectancy in the US rose 0.6 years from 2023 to 2024, reaching 79.0 years. The increase stemmed mainly from lower mortality in unintentional injuries, COVID-19, heart disease, and cancer. Provisional CDC data show the upward trend held across most age groups, moving the national average past the previous high point recorded in 2014.
International Comparisons
Despite the domestic recovery, life expectancy in the US still trails peer high-income countries. In 2024 the US figure stood at 79.0 years while the average for comparable nations reached 82.7 years, a gap of 3.7 years. That difference narrowed slightly from 4.1 years the prior year, yet the United States remains behind on this key health metric.
Recent Trends in Drug Overdose Mortality
Drug overdose deaths, once a steady drag on life expectancy in the US, have reversed course. Provisional counts show a third straight annual decline in 2025, bringing totals near 70,000 and roughly back to pre-pandemic levels. The drop reflects changes in both supply patterns and public health responses that began gaining traction after the 2021 peak.
Updated Leading Causes of Death
Heart disease, cancer, and unintentional injuries now form the top three causes of death. Suicide ranks tenth, while COVID-19 has fallen out of the top ten entirely. Age-adjusted death rates declined for every cause in the current top ten, a broad improvement that supports the continued rise in life expectancy in the US.
The data show a clear arc from the 2020 shock through steady recovery to a new record in 2024. Life expectancy in the US now sits above its prior peak, yet the persistent gap with peer nations and the remaining influence of drug overdoses and chronic disease keep the metric under close watch. Ongoing trends in mortality will determine whether the recent gains hold or shift again.
